CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Structure
Contacts
For Advertisers
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
For Authors
General Information
Scope
Submit Article
Author Instructions
Open Access
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Library Recommendation

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Submit Article
blank image
Use the online submission system to send us your paper.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

 

Article << Previous     |     Next >>   Contents Vol 7(3)

Low rates of free human papillomavirus vaccine uptake among young women

Gregory R. Moore A B C, Richard A. Crosby B D E, April Young B, Richard Charnigo B

A University Health Service, University of Kentucky, 830 South Limestone, Lexington, KY 40536-0582, USA.
B College of Public Health, University of Kentucky, 121 Washington Avenue, Lexington, KY 40536-0003, USA.
C College of Medicine, University of Kentucky, 740 South Limestone Street, Lexington, KY 40508, USA.
D Rural Cancer Prevention Center, University of Kentucky, 138 Leader Avenue, Lexington, KY 40506-9983, USA.
E Corresponding author. Email: Crosby@uky.edu
 
PDF (101 KB) $25
 Export Citation
 Print
  


Abstract

Objective: To determine uptake of quadrivalent human papillomavirus recombinant vaccine (quadrivalent; Gardasil®, Merck, New Jersey, USA) offered under optimal conditions to women 18 to 24 years of age, and to identify predictors of uptake. Methods: Young women (n = 209) were recruited from a university health clinic. After completing a self-administered questionnaire, women received a free voucher for the entire vaccine series. Results: Only 59 women (28.2%) who were offered this free service completed the series. Just over half (50.7%) received the first dose. Of those, 78.3% returned to receive the second and 55.7% returned for the third. Young women who felt their mothers might not want them to be vaccinated were much less likely to complete the series compared with those who felt their mothers would ‘definitely’ want them to be vaccinated (P = 0.0002). Also, young women who indicated that they would take the time to return to the clinic for doses two and three were far more likely to complete the series (P = 0.0004). Several measures failed to achieve even bivariate significance with vaccine uptake, including being sexually active in the past 12 months, ever having a Pap test or an abnormal Pap test result, and ever having a sexually transmissible infection. Conclusions: Even under ideal conditions, uptake of Gardasil among women 18–24 years of age may be quite low. Maternal endorsement and young women’s perceptions about the time needed to return for subsequent doses are important determinants of vaccine uptake. Fortunately, these two determinants lend themselves to intervention efforts.

Keywords: female university students.


   
Subscriber Login
Username:
Password:  

    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2016